Electromed, Inc. to Participate in the 2024 Canaccord Global Growth Conference
07 Agosto 2024 - 5:05PM
Business Wire
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American:
ELMD), a leader in innovative airway clearance technologies, today
announced that Jim Cunniff, President and Chief Executive Officer,
and Brad Nagel, Chief Financial Officer, are scheduled to attend
the Canaccord Genuity 44th Annual Global Growth Conference being
held in Boston on August 13-15, 2024.
Electromed’s management team will present at 2:30 p.m. Eastern
Time on Wednesday, August 14, 2024. A link to the live and archived
webcast of the event will be available on the Electromed website
under Events & Presentations. You can also access the live
webcast here.
In advance of the event, Electromed has published an updated
investor presentation deck for review by interested parties. The
updated presentation can be found on the Electromed website at
Events & Presentations or on the SEC website at
www.sec.gov.
About Electromed, Inc.
Electromed, Inc. manufactures, markets, and sells products that
provide airway clearance therapy, including the SmartVest® Airway
Clearance System, to patients with compromised pulmonary function.
It is headquartered in New Prague, Minnesota, and was founded in
1992. Further information about Electromed can be found at
www.smartvest.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240807855974/en/
Mike Cavanaugh, Investor Relations ICR Westwicke (617) 877-9641
mike.cavanaugh@westwicke.com
Electromed (AMEX:ELMD)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Electromed (AMEX:ELMD)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025